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Objective: The fallopian tubes play a critical role in the early events of fertilization. The rapid innate immune defense is an important part of 
the fallopian tubes. Toll-like receptor 3 (TLR3), as a part of the innate immune system, plays an important role in detecting viral infections. In 
this basic and experimental study, the efect of sex hormones on the function of TLR3 in the OE-E6/E7 cell line was investigated. 
Methods: The functionality of TLR3 in this cell line was evaluated by cytokine measurements (interleukin [IL]-6 and IL-1b) and the efects of sex 
hormones on TLR3 were tested by an enzyme-linked immunosorbent assay kit. Additionally, TLR3 small interfering RNA (siRNA) and a TLR3 
function-blocking antibody were used to conirm our indings. 
Results: The production of IL-6 signiicantly increased in the presence of polyinosinic-polycytidylic acid (poly(I:C)) as the TLR3 ligand. Using a 
TLR3-siRNA-ransfected OE-E6/E7 cell line and function-blocking antibody conirmed that cytokine production was due to TLR3. In addition, 
17-β estradiol and progesterone suppressed the production of IL-6 in the presence and absence of poly(I:C). 
Conclusion: These results imply that sex hormones exerted a suppressive efect on the function of TLR3 in the fallopian tube cell line when dif-
ferent concentrations of sex hormones were present. The current results also suggest that estrogen receptor beta and nuclear progesterone re-
ceptor B are likely to mediate the hormonal regulation of TLR3, as these two receptors are the main estrogen and progesterone receptors in OE-
E6/E7 cell line.
Keywords: Estrogen; Fallopian tube epithelial cells; Innate immunity; Progesterone; Toll-like receptor 3
Introduction
The fallopian tubes play a critical role in human reproduction. They 
function as sperm reservoirs, and enhance the motility, preserve the 
viability, and induce capacitation of sperm [1,2]. Epithelial cells on 
the luminal surface of the fallopian tubes provide an optimum envi-
ronment for the fertilization and early cleavage stage of embryonic 
development, as they are in direct cell-to-cell contact with gametes 
and the embryo [3,4]. Therefore, infection within the upper sections 
of the female reproductive tract, particularly the fallopian tube, can 
have serious consequences, such as chronic pelvic inlammation, in-
fertility, and pregnancy complications [5,6]. Thus, it is crucial that in-
fectious agents be quickly recognized and removed from the upper 
parts of the female reproductive tract. 
Although the physiological roles of the fallopian tubes and the lu-
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minal epithelial cells are well established, insuicient knowledge ex-
ists regarding the maintenance of the immune system in this organ. 
Moreover, it has become clear that the immune system in the fallopi-
an tubes is regulated by the circulating estradiol and progesterone 
hormones in order to enable the reproductive process that occurs in 
the fallopian tube to progress [7-9]. 
The body’s irst line of defense against infection is the innate im-
mune system. Rapid innate immune defenses against microbial in-
fections usually involve the recognition of invading pathogens by 
speciic pattern recognition receptors, which is attributed to the fam-
ily of Toll-like receptors (TLRs) [10]. Thirteen members of this group of 
receptors have been discovered. TLRs 11–13 have been only discov-
ered in mice, not in humans. TLRs 1–10 function in humans and rec-
ognize distinct pathogen-associated molecular patterns produced 
by various bacterial, fungal, and viral pathogens. Toll-like receptor 3 
(TLR3) recognizes double-stranded RNA (dsRNA) [11], a molecular 
signature of RNA viruses [12]. Thus, it is likely that TLR3 plays a physi-
ologic role in antiviral innate immunity [13,14]. 
dsRNA is produced during RNA viral infection and induces antiviral 
responses in host cells through a TLR3-mediated signaling pathway. 
Polyinosinic-polycytidylic acid (poly(I:C)) is a form of synthetic dsRNA 
that binds TLR3 and elicits various cellular responses similar to those 
caused by viral infection [11,13]. Furthermore, this synthetic ana-
logue of dsRNA is sensed by TLR3, which also activates adaptive im-
munity when it is used as a vaccine adjuvant [15]. The induction of 
TLR3 signaling via dsRNA activates transcription factors such as nu-
clear factor kappa-B (NFκB) and interferon regulatory factor 3, result-
ing in the production of proinflammatory and antiviral cytokines 
[11,16-21]. 
Numerous studies have demonstrated the existence of this recep-
tor in diferent parts of the female reproductive tract [22-26]. Addi-
tionally, we have documented the expression of TLR3 in various en-
dometrial epithelial cell lines [27]. Several reports have demonstrated 
the cycle-dependent expression of TLR3 in the endometrium or fal-
lopian tube [28-31]. We also previously demonstrated that TLR3 ex-
pression is independent of estradiol and is therefore potentially sus-
tained throughout the menstrual cycle to aid in the defense of the 
uterus against potential pathogens [32]. Despite many studies in 
these ields and the importance of the fallopian tube in many physi-
ological and pathological events, few studies have sought to under-
stand the function of TLR3 and its speciic role in maintaining innate 
immunity in the human fallopian tube. 
In the present study, we used an immortalized human oviductal 
epithelial cell line OE-E6/E7 [33] as a model of human fallopian tube 
epithelium. Our previous study demonstrated that OE-E6/E7 ex-
pressed TLR3 through an analysis of messenger ribonucleic acid 
(mRNA) and protein levels [34]. Therefore, in this study, proinlamma-
tory cytokine and chemokine production by these cells was evaluat-
ed using a synthetic analogue of dsRNA. To conirm these results, a 
TLR3-small interfering RNA (siRNA)-transfected OE-E6/E7 cell line 
was used. Finally, sex hormonal regulation of TLR3 in this cell line and 
the potential efects of estradiol and progesterone on the function of 
TLR3 in OE-E6/E7 were also investigated. For further conirmation of 
our indings, the level of gene expression of NFκB, an important me-
diator in the TLR3 signaling pathway, was also evaluated.
Methods
1. Characterization of TLR3 mRNA expression in OE-E6/E7 cells 
by reverse-transcription polymerase chain reaction and 
immunostaining
TLR3 mRNA expression in the OE-E6/E7 cell line was investigated 
using reverse-transcription polymerase chain reaction (RT-PCR). OE-
E6/E7 cells were cultured in a T75 culture dish using regular media as 
previously described till conluence at 37°C. At conluence, cells were 
washed with Ca2+ and Mg2+-free phosphate-buffered saline (PBS) 
and were harvested using trypsin-ethylenediaminetetraacetic acid 
(EDTA; Invitrogen, Waltham, MA, USA), pelleted by centrifugation at 
300 × g for 5 minutes. One milliliter of TRI reagent (Sigma, St. Louis, 
MO, USA) was added onto the pellet (5× 106 cells). Thereafter, total 
RNA from pelleted cells was extracted following the standard proto-
col supplied by the manufacturer.
The total RNA obtained from OE-E6/E7 cells was treated with DN-
ase I (DNA-free, Ambion, Huntingdon, UK) to remove genomic DNA 
contamination from the samples. First-strand complementary DNA 
(cDNA) synthesis was performed using oligo-dT primers (Metabion, 
Martinsried, Germany), and reverse transcription was done by Super-
Script II (200 U/µL, Invitrogen). Negative controls were prepared 
without the enzyme (non-RT controls, RT-negative controls). 
PCR was performed with the prepared cDNA, the Platinum Blue 
PCR Super Mix (Invitrogen), and the appropriate primer sets (Metabi-
on). The forward primer was 5’-GTA TTG CCT GGT TTG TTA ATT GG-3’, 
and the reverse primer was 5’-AAG AGT TCA AAG GGG GCA CT-3’, 
with a product size of 156 bp. PCR products were separated on a 
1.2% agarose gel. The amplified PCR products were sequenced to 
conirm the identity of the ampliied product.
For immunostaining, the human fallopian tube epithelial cell line 
OE-E6/E7 was cultured in 4-well-chamber slides. The antibody (goat 
polyclonal antibody specific for N-terminal domains of TLR3, cata-
logue no. sc8691) used in the experiments were obtained from Santa 
Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Formalin-ixed slides 
were washed in PBS and then stained using a Vectastain Elite ABC 
peroxidase kit (Vector Laboratories, Peterborough, UK). Optimum 
staining was achieved by incubating sections with 10 mg/mL TLR3 
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antibody. Control sections were obtained by omission of the primary 
antibody. Immunostained sections were examined using an Olym-
pus BH2 microscope (Olympus, London, UK).
2. Characterization of TLR3 function in OE-E6/E7 cells
To study the functionality of TLR3 in OE-E6/E7 cells, they were ex-
posed to the TLR3-speciic ligand, poly(I:C), and the levels of interleu-
kin (IL)-1b and IL-6 were detected in the culture media using an en-
zyme-linked immunosorbent assay (ELISA). Finally, to determine 
whether cytokine elevation after treatment with poly(I:C) was medi-
ated via TLR3, a TLR3 siRNA kit (ksirna42-htlr3, Invitrogen) was used 
to silence the function of TLR3.
Cells were cultured on 4-well-plate culture dishes until they were con-
luent. The supernatant was then replaced with 1 mL of fresh culture 
medium containing the synthetic TLR3 ligand, poly(I:C) (25 μg/mL; 
Amersham Biosciences, Piscataway, NJ, USA). Under these conditions, 
the supernatant was collected 24 hours after stimulation and centri-
fuged at 300 × g for 5 minutes at 4°C and stored at –70°C until used in 
ELISA. Experiments were performed in triplicate. The concentrations of 
IL-1b and IL-6 were determined in each supernatant with commercially 
available ELISA kits (R&D Systems, Minneapolis, MN, USA). 
To determine the role of TLR3 in elevating cytokine levels in re-
sponse to poly(I:C) in OE-E6/E7 cells, these cells were exposed to 
TLR3-siRNA. In this procedure, OE-E6/E7 cells were transfected using 
a recombinant plasmid according to the procedure described in the 
kit. Two days after transfection, Zeocin (10 µg/mL) was added to the 
cells and stable transfectants were individualized after 1 week. The 
OE-E6/E7 cell line that was transfected with TLR3-siRNA was firstly 
evaluated for TLR3 expression, as indicated by mRNA and protein 
levels, and then stimulated with poly(I:C) for 24 hours. Thereafter, the 
concentrations of IL-1b and IL-6 were measured using ELISA. Samples 
in which no cytokines could be detected were assigned values 
equivalent to the lower limit of the values detected in the assay 
(18.75 pg/mL).
For further confirmation, cells were exposed to a TLR3 function-
blocking antibody. OE-E6/E7 cells were pretreated with an anti-TLR3 
monoclonal antibody (catalogue no. sc-32232, Santa Cruz Biotech-
nology) at a inal concentration of 20 μg/mL for 1 hour at 37°C, then 
stimulated with poly(I:C) for 24 hours. The inal concentrations of IL-
1b and IL-6 were then measured using ELISA.
3. Determination of the effects of sex hormones on TLR3 
function
To investigate the efect of estradiol and progesterone on the func-
tion of TLR3 in OE-E6/E7 cells, these cells were cultured in triplicate in 
Dulbecco’s Modiied Eagle’s medium (F12). Thereafter, the cells were 
treated with estradiol and progesterone (Sigma-Aldrich, St. Louis, 
MO, USA) at inal concentrations of 0, 1, 10, and 1,000 nM for estradi-
ol and progesterone in 12-well plates. After 24 hours of treatment 
with various concentrations of the sex hormones, triplicate wells 
were stimulated with the TLR3 ligand. Cells were stimulated with 
poly(I:C) and the double-stranded DNA negative control, polydeoxy-
inosinic-deoxycytidylic acid (poly dI:dC; 10 μg/mL, Amersham Biosci-
ences). The supernatant of each well was collected after 24 hours of 
stimulation, centrifuged at 300 × g for 5 minutes at 4°C, and stored at 
–70°C until used for ELISA. The concentration of IL-6 was determined 
in each supernatant with a commercially available ELISA kit (R&D 
Systems). 
4. Evaluation of the effects of sex hormone antagonists on 
TLR3 function
For hormone receptor antagonist experiments, cells were pretreat-
ed for 2 hours with 1 µM ICI 182, 780 (fulvestrant, an estrogen antag-
onist; Sigma-Aldrich) or 0.1 µM RU486 (mifepristone, a progesterone 
antagonist; Tocris, St. Louis, MO, USA). Cells were then treated with 10 
nM 17-β estradiol or 10 nM progesterone. Triplicate wells were used 
for each condition. After 24 hours of treatment, the triplicate wells 
were stimulated with the ligand (25 µg/mL poly(I:C)). The superna-
tant of each well was collected after 24 hours of stimulation and cen-
trifuged at 300 × g for 5 minutes at 4°C, transferred to fresh tubes, 
and stored at –70°C until use. The concentration of IL-6 was again de-
termined in each supernatant using a commercially available ELISA 
kit (R&D Systems). For further conirmation, the level of NFκB, an im-
portant mediator of TLR3, was also evaluated in each group using RT-
PCR.
The results were expressed as mean ± standard error. Statistical 
analysis was performed using analysis of variance, and the Tukey 
multiple comparison test was used to determine significant differ-
ences between different groups. The p-values < 0.05 were consid-
ered to indicate statistical signiicance.
Results
1. TLR3 mRNA and protein presence in OE-E6/E7 using RT-PCR 
and immunostaining
Formalin-ixed slides were used to study the distribution of TLR3 in 
OE-E6/E7 cells. Strong positive immunostaining for TLR3 was ob-
served in the cytoplasm, but not in the cell membrane (Figure 1A). 
Figure 1B shows the results of RT-PCR for mRNA expression of the 
TLR3 gene in OE-E6/E7 cells. The ampliied product was the predicted 
size for the TLR3 gene. The amplified PCR product was sequenced 
and conirmed to be the TLR3 gene. No product was ampliied in the 
RT-control samples, indicative of the absence of genomic DNA con-
tamination. 
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2. Characterization of TLR3 function in OE-E6/E7 cells with and 
without TLR3-siRNA and TLR3 function-blocking antibody 
and determination of the effects of sex hormones on TLR3 
function
Figure 2 shows that the OE-E6/E7 cells were successfully transfect-
ed, as shown by mRNA and protein levels. The OE-E6/E7 cells did not 
produce any detectable amount of IL-1b in the presence or absence 
of the TLR3 ligand. However, the production of IL-6 signiicantly in-
creased in the presence of the TLR3-speciic ligand, poly(I:C) (Figure 
3). Using transfected cells with TLR3 siRNA and the TLR3 function-
blocking antibody, the increase in the production of IL-6 by poly(I:C) 
was completely blocked (Figure 3).
The efects of poly(I:C) and poly(dI:dC) on the production of IL-6 in 
the presence of 17-β estradiol are shown in Figure 4. The production 
of IL-6 was signiicantly higher in the presence of poly(I:C) with difer-
ent levels of estrogen, in comparison to other conditions (only bufer 
or only poly(dI:dC) (Figure 4). Additionally, the same efect of the TLR-
3 ligand on the production of IL-6 in the presence of diferent levels 
of progesterone was observed (Figure 5).
3. The effect of sex hormone antagonists on TLR3 function
As depicted in Figure 6, the efects of estrogen and progesterone 
on the production of IL-6 were speciic. By using 1 µM fulvestrant (an 
estrogen antagonist) 2 hours before estrogen treatment in the cul-
ture medium, the suppressive efect of estrogen on the production 
of IL-6 was signiicantly reduced (Figure 6A). Additionally, by using 0.1 
µM mifepristone (a progesterone antagonist) 2 hours before proges-
Figure 1. Immunohistochemical staining of Toll-like receptor 3 (TLR3) 
expression in OE-E6/E7 cells. Positive staining is red and negative 
staining is blue. Small inserts show blocking of the anti-TLR3 antibod-
ies with the corresponding speciic peptide. (A) TLR3 gene expression 
was positive in this human fallopian tube cell line (OE-E6/E7; magnii-
cation, × 40). (B) The pair of TLR3 primers produced a speciic product 
with the predicted size in the test T and control C samples.
A B
250 bp
100 bp
Figure 2. The OE-E6/E7 cells were successfully transfected, as shown 
in mRNA (messenger ribonucleic acid) level by quantitative poly-
merase chain reaction (A) and in protein level by Western blot analy-
sis (B). si-TLR3, transfected siRNA for TLR3.
A 25
20
15
10
5
0
N
o
rm
al
iz
ed
 e
xp
re
ss
io
n
Control
OE-E6/E7 cell line
TLR3 mRNA expression
si-TLR3
B 3.0
2.5
2.0
1.5
1.0
0.5
0
N
o
rm
al
iz
ed
 e
xp
re
ss
io
n
Control
OE-E6/E7 cell line
TLR3 protein expression
si-TLR3
Figure 3. Interleukin (IL)-6 production in the presence of the Toll-like 
receptor 3 (TLR3)-speciic ligand, poly(I:C), in the OE-E6/E7 cell line. 
TLR3 small interfering RNA (siRNA) (A) and a TLR3 function-blocking 
antibody (Ab) (B) were used for data conirmation. Poly(I:C), polyino-
sinic-polycytidylic acid. a)Indicates the significant differences be-
tween groups.
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terone treatment, the production of IL-6 was signiicantly increased 
in comparison to progesterone treatment alone (Figure 6B). Figure 7 
demonstrates the level of NFκB mRNA expression in response to ful-
vestrant and mifepristone. The results show that the level of NFκB in 
response to mifepristone and fulvestrant before progesterone and 
estrogen treatment, respectively, was signiicantly higher than that 
observed in response to progesterone and estrogen alone.
 
Figure 4. (A-D) The efects of poly(I:C) and poly(dI:dC) on the production of interleukin (IL)-6 in the presence of diferent concentrations of 17-β 
estradiol (E). Poly(I:C), polyinosinic-polycytidylic acid; Poly(dI:dC), poly(deoxyinosinic-deoxycytidylic) acid. a)Indicates the signiicant diferences 
between groups.
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Figure 5. (A-E) The efects of poly(I:C) and poly(dI:dC) on the produc-
tion of interleukin (IL)-6 in the presence of diferent concentrations of 
progesterone (P). Poly(I:C), polyinosinic-polycytidylic acid; poly(dI:dC), 
poly(deoxyinosinic-deoxycytidylic) acid. a)Indicates the signiicant dif-
ferences between groups.
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Discussion
The present study characterized the expression and function of 
TLR3 in this fallopian tube cell line by measuring the production of 
IL-6 in response to poly(I:C). In addition, we established that both sex 
hormones suppressed the production of IL-6 in the presence and ab-
sence of the TLR3 ligand. 
Several studies have examined the presence and the role of TLRs in 
the female reproductive tract. Nonetheless, the efect of sex hormone 
regulation on these molecules within the fallopian tube has not been 
completely identified. Previously, we described the localization of 
TLR3 in the fallopian tube using immunohistochemistry [23,31]. Pioli 
et al. [35] demonstrated the presence of TLRs 1–6 in the female repro-
ductive tract. They also observed the expression of TLR3 mRNA in the 
fallopian tubes. In addition to our study, which proposed that TLRs are 
subject to hormonal regulation, as shown by a higher level of the ex-
pression of all TLRs during the secretory phase of the menstrual cycle 
in human endometrium in vivo [28], other reports have investigated 
the efects of sex hormones on the expression and function of TLRs in 
the female reproductive tract [8,25,29, 31,32]. An experiment on uter-
ine epithelial cells demonstrated the presence of a robust interferon 
beta–mediated response of whole blood cells to poly(I:C), which was 
unafected by estradiol in human uterine epithelial cells [32]. Another 
study of uterine epithelial cells showed that 17-β estradiol inhibited 
the TLR-agonist-induced secretion of tumor necrosis factor α and 
macrophage Inlammatory protein-3 (MIP3a). In addition to, lipopoly-
saccharide increased IL-6 expression in these cells, and this upregula-
tion by estradiol pretreatment was completely abrogated [8,36]. 
However, few studies have investigated the role of sex hormones in 
TLR function in the fallopian tube. In our previous study, we demon-
strated in a study using the OE-E6/E7 cell line that the combination of 
estradiol and progesterone modulated TLR expression [31] and 
showed that TLR3 is expressed in the human oviduct and that estra-
diol suppressed TLR3-induced cytokine and chemokine production in 
human endometrial epithelial cells. Wira et al. [8] showed that sex 
hormones suppressed the innate, humoral, and cell-mediated im-
mune system in the upper and lower parts of the female reproductive 
tract. Although none of these studies were done on the fallopian 
tube, they almost completely agree with our results that innate im-
munity is modulated by estradiol and progesterone.
TLR3 is activated by dsRNA and plays an important role in the in-
nate immune response directed against dsRNA viral pathogens by 
coupling to Toll/interleukin-1 receptor domain-containing adapter 
protein-dependent signal transduction pathways [11,37]. TLR3 can 
Figure 6. The inluence of pretreatment with fulvestrant (F, A) and 
mifepristone (M, B) on the production of interleukin (IL)-6 after treat-
ment with 10 nM 17-β estradiol (E10) and progesterone (P10) in the 
presence of poly(I:C). Poly(I:C), polyinosinic-polycytidylic acid. a)Indi-
cates the signiicant diferences between groups.
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Figure 7. The influence of pretreatment with fulvestrant (F, A) and 
mifepristone (M, B) on nuclear factor kappa-B (NFκB) gene expression 
after treatment with 10 nM 17-β estradiol (E10) and progesterone 
(P10) in the presence of poly(I:C). Poly(I:C), polyinosinic-polycytidylic 
acid. a)Indicates the signiicant diferences between groups.
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mediate responses to the synthetic analogue of viral dsRNA, poly(I:C), 
which has been used extensively in experimental studies to mimic 
viral infection [11]. Ank et al. [38] have suggested that type III inter-
feron targets a speciic subset of cells, contributing to the antiviral re-
sponse evoked by TLR3. It has been assumed that TLR3 plays a key 
role in antiviral immunity against a variety of viruses [39]. In murine 
oviductal epithelial cells, data implicate TLR3 as an essential inducer 
of interferon-beta and other inflammatory mediators by epithelial 
cells during Chlamydia infection, highlighting the contribution of 
TLR3 to the inlammatory cytokine response [40].
IL-6 is one of the key mediators that orchestrate host immunoin-
flammatory responses to viral infections [10]. In this study, we 
showed that estrogen and progesterone exerted a suppressive efect 
on the production of IL-6 in the presence and absence of the TLR3 li-
gand. Interestingly, a study investigating IL-6 expression in mouse 
and human fallopian tube epithelium, showed that 17-β estradiol 
suppressed the expression of IL-6 receptors present in the cilia of epi-
thelial cells [41]. 
The nuclear estrogen receptor alpha (ERα) [42] was long considered 
to be the only estrogen receptor and thus responsible for all actions 
of estrogen. Since the discovery of the second nuclear estrogen re-
ceptor, ERβ [43], it has become evident that ERα and ERβ not only are 
encoded by separate genes, but also possess diferent functions and 
transcriptional activity [44-46]. In the rat oviduct epithelium, only the 
ERα subtype is expressed [47], while immunolocalization studies in 
humans have demonstrated the presence of both estrogen receptors 
(ERα and ERβ) in fallopian tube epithelial cells [48]. Our published 
data indicate that ERβ is the only nuclear receptor for estrogen ex-
pressed in the OE-E6/E7 cell line [49]. In the present study, we used 
fulvestrant, which is an antagonist of both ERα and ERβ, to investi-
gate whether the suppressive effect of estrogen on TLR3 function 
was mediated by estrogen receptors. Considering that only ERβ 
seems to be present in this cell line, and the fact that in the presence 
of fulvestrant, estrogen was no longer capable of inhibiting TLR3 
function, ERβ is likely to mediate the hormonal regulation of TLR3. 
However, given the complexity of estrogen signaling and its modula-
tion in vivo, direct conclusions regarding the ERβ-mediated regula-
tion of TLRs in humans in vivo cannot be drawn based on our data, 
and further investigations are needed. In recent years, the evaluation 
of estrogen signaling pathways has become more complicated than 
ever, as completely novel aspects of estrogen signaling have 
emerged. A number of reports have provided evidence of functional 
G protein–coupled receptors for estrogen [50-52]. Some of these 
studies have reported receptor localization on the plasma mem-
brane [52], while others, unexpectedly, have found these receptors 
to be present in the endoplasmic reticulum [51]. Clearly, more stud-
ies are needed to clarify the role of these classes of estrogen recep-
tors in reproductive physiology. Nonetheless, our data strongly point 
to the modulation of TLR3 function by ERβ in fallopian tube epithelial 
cells.
We previously showed that the membrane receptors for progester-
one (mPRα and mPRβ) were both expressed in the OE-E6/E7 cell line. 
However, the expression level of mPRβ was very low. Additionally, 
the nuclear PR-B receptor subtype was found to be expressed in 
these cells, as well as a PCR product common to the PR-A and PR-B 
subtypes. The expression level of PR-A,B and PR-B was very similar 
[49]. Thus, we concluded that PR-B is primarily present in the OE-E6/
E7 line. In the present investigation, we used mifepristone, which is a 
progesterone nuclear receptor antagonist that can block both PR-A 
and PR-B, as well as nuclear corticosteroid receptors. Considering 
that only mPRα and nuclear PR-B receptors generally seem to be 
present in this cell line, the fact that in the presence of mifepristone 
as a progesterone nuclear receptor antagonist, progesterone was no 
longer capable of inhibiting TLR3 function suggests either that mife-
pristone can block the function of mPRα or that this membrane re-
ceptor does not mediate the hormonal regulation of TLR3. The cur-
rent data strongly point to the modulation of TLR3 function by PR-B 
in fallopian tube epithelial cells.
In conclusion, our study demonstrated that TLR3 function in the 
human oviductal epithelial cell line OE-E6/E7 is regulated by sex hor-
mones. Clinically, this fact could be quite signiicant for controlling 
the immune antiviral response to pathogenic viral infections invad-
ing the female reproductive tract. Further experiments should eluci-
date the regulatory mechanism behind the efect of sex hormones in 
women, as well as the functional efect that they might have in mod-
ulating innate immunity in the human female reproductive tract. 
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